Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • Compensation Framework Study
    • First Interim Report
    • Second Interim Report
    • The Inquiry Report
  • Publication Day
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • Confidential Psychological Support
    • Interim Payments
    • Support Groups
    • Get in touch
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

Dr Gunson and others were working on a journal article reporting on the pilot study.

  • Read more about Dr Gunson and others were working on a journal article reporting on the pilot study.

Dr Rejman commented in his written statement that his understanding was that national implementation of Hepatitis C screening should be coordinated to avoid possible medico-legal complications in the future, which was a common view.

  • Read more about Dr Rejman commented in his written statement that his understanding was that national implementation of Hepatitis C screening should be coordinated to avoid possible medico-legal complications in the future, which was a common view.

In his written evidence to the Inquiry, Professor Allain stated that the start of anti-HCV screening should have been on 1 August 1991 to ensure that labile blood products were already tested at the official starting date.

  • Read more about In his written evidence to the Inquiry, Professor Allain stated that the start of anti-HCV screening should have been on 1 August 1991 to ensure that labile blood products were already tested at the official starting date.

The view of David McIntosh of the Scottish National Blood Transfusion Service in his evidence to this Inquiry was that: "misplaced desire for Anglo-Scottish solidarity was the clear cause of the unnecessary delays in the universal implementation of HCV testing in Scotland."

  • Read more about The view of David McIntosh of the Scottish National Blood Transfusion Service in his evidence to this Inquiry was that: "misplaced desire for Anglo-Scottish solidarity was the clear cause of the unnecessary delays in the universal implementation of HCV testing in Scotland."

Funding did not appear to have presented a challenge to the Scottish National Blood Transfusion Service in relation to starting the anti-HCV screening tests.

  • Read more about Funding did not appear to have presented a challenge to the Scottish National Blood Transfusion Service in relation to starting the anti-HCV screening tests.

Dr Boulton's view at the time of providing his statement to the Inquiry was that the UK Blood Transfusion Service should have introduced HCV screening in 1990 and this should have been fully funded.

  • Read more about Dr Boulton's view at the time of providing his statement to the Inquiry was that the UK Blood Transfusion Service should have introduced HCV screening in 1990 and this should have been fully funded.

In his written statement to the Inquiry, Dr Boulton explained that "'litigation' should be viewed as a sort of surrogacy for 'responsible practices'", which would involve balancing the need to secure clinical supplies of donor blood with patient welfare and the minimisation of risk, even using an imperfect testing method.

  • Read more about In his written statement to the Inquiry, Dr Boulton explained that "'litigation' should be viewed as a sort of surrogacy for 'responsible practices'", which would involve balancing the need to secure clinical supplies of donor blood with patient welfare and the minimisation of risk, even using an imperfect testing method.

The Cambridge regional transfusion centre officially started anti-HCV testing on the nationally coordinated date of 1 September 1991.

  • Read more about The Cambridge regional transfusion centre officially started anti-HCV testing on the nationally coordinated date of 1 September 1991.

Dr Diana Walford, in a memo to John Harley, said when describing non-A non-B Hepatitis: "This form of hepatitis can be rapidly fatal (particularly when acquired by patients with pre-existing liver disease) or can lead to progressive liver damage".

  • Read more about Dr Diana Walford, in a memo to John Harley, said when describing non-A non-B Hepatitis: "This form of hepatitis can be rapidly fatal (particularly when acquired by patients with pre-existing liver disease) or can lead to progressive liver damage".

Dr McIntyre, who attended the Advisory Committee on the Virological Safety of Blood meeting as an observer on behalf of the Scottish Home and Health Department, stated with regard to the date of introduction of testing that "Some wanted to start forthwith but the Chairman suggested that 1 April 1991 might be more realistic."

  • Read more about Dr McIntyre, who attended the Advisory Committee on the Virological Safety of Blood meeting as an observer on behalf of the Scottish Home and Health Department, stated with regard to the date of introduction of testing that "Some wanted to start forthwith but the Chairman suggested that 1 April 1991 might be more realistic."

Pagination

  • First page « First
  • Previous page ‹ Previous
  • …
  • Page 235
  • Page 236
  • Page 237
  • Page 238
  • Current page 239
  • Page 240
  • Page 241
  • Page 242
  • Page 243
  • …
  • Next page Next ›
  • Last page Last »
Subscribe to

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.